Short Bowel Syndrome Clinical Trials

154 clinical trials for Short Bowel Syndrome across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS — RECRUITING · PHASE3
• A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome — RECRUITING · NA
• Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects — RECRUITING · PHASE2
• A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) — RECRUITING · PHASE3
• A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB — RECRUITING · NA
• A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice-Weekly, Followed by a Long-Term, Open-Label Safety Evaluation in Patients with Short Bowel Syndrome–Intestinal Failure (SBS-IF) — RECRUITING · PHASE3
• Resting Energy Expenditure by Gastrointestinal Functional Status — RECRUITING · NA
• A Clinical Study of FT1 in Patients With Short Bowel Syndrome — RECRUITING · PHASE2
• A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB — RECRUITING
• A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome — RECRUITING · PHASE3
• Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) — RECRUITING · PHASE2
• A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome — RECRUITING
• Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition — RECRUITING · PHASE3
• SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL) — RECRUITING
• Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome — RECRUITING · PHASE1
• TED_ORG: Study on Short Bowel Syndrome — RECRUITING · NA
• Palliative Care Needs of Children With Rare Diseases and Their Families — RECRUITING · NA
• A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey) — RECRUITING
• A 104-WEEK, MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE LONG-TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) ROLLING OVER FROM THE EASE SBS 2 OR 3 TRIALS — RECRUITING · PHASE3
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — RECRUITING
• EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study) — RECRUITING · PHASE4
• Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome — RECRUITING · PHASE1
• A 24-WEEK DOUBLE-BLIND, SAFETY, EFFICACY, AND PHARMACODYNAMIC STUDY INVESTIGATING TWO DOSES OF TEDUGLUTIDE IN PEDIATRIC SUBJECTS THROUGH 17 YEARS OF AGE WITH SHORT BOWEL SYNDROME WHO ARE DEPENDENT ON PARENTERAL SUPPORT — RECRUITING
• Clinical trial to investigate efficacy and safety of FE 203799 (GLP-2 analogue) or placebo administered as subcutaneous injections once weekly in two treatment periods followed by FE 203799 once weekly in one treatment period to patients with short bowel syndrome with intestinal failure. — COMPLETED · PHASE2
• An open-label phase Ib / IIa metabolic balance test of FE 203799 in patients with short-term syndrome — COMPLETED · PHASE2
• A research study to learn how safe, efficacious and tolerated over 24 weeks of time teduglutide (the study medication) is when given to paediatric patients of up to 17 years of age who are suffering from short bowel syndrome. — COMPLETED · PHASE3
• A Study of Teduglutide in Japanese People With Short Bowel Syndrome — COMPLETED
• Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome — ACTIVE_NOT_RECRUITING · PHASE3
• Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. — COMPLETED · NA
• A 104-week, multicenter, open-label, single-arm, phase 3 extension trial investigating the long-term safety and efficacy of Glepaglutide in adult patients with short bowel syndrome (SBS) rolling over from the EASE SBS 2 or 3 trials — TERMINATED · PHASE3
• An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend) — TERMINATED · PHASE3
• Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome — COMPLETED · PHASE3
• Role of the Microbiota in Intestinal Adaptation During Short Bowel Syndrome — NOT_YET_RECRUITING · NA
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS — ACTIVE_NOT_RECRUITING · PHASE3
• Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome — COMPLETED · NA
• A 104-WEEK, MULTICENTER, SINGLE-ARM, LONG-TERM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) COMPLETING THE EASE SBS 2 TRIAL — OTHER · PHASE3
• A DOUBLE-BLIND PHASE 3 EXTENSION TRIAL ASSESSING THE LONG TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME (SBS) — OTHER · PHASE3
• Registry for Participants With Short Bowel Syndrome — ACTIVE_NOT_RECRUITING
• Effect of Parenteral Support on FibroScan in Short Bowel Syndrome — NOT_YET_RECRUITING
• Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition — COMPLETED · NA
• Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation. — COMPLETED · NA
• Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients — COMPLETED · PHASE4
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) — COMPLETED · PHASE3
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. — ACTIVE_NOT_RECRUITING · PHASE3
• Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC) — COMPLETED · PHASE2
• Intralipid Versus SMOFlipid in HPN Patients — COMPLETED · NA
• A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada — COMPLETED
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) — COMPLETED · PHASE3
• Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study — COMPLETED · PHASE3

Refine this search